Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 USD | 0.00% | -6.15% | -30.18% |
13/05 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
09/05 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.18% | 112.41Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.86% | 1.7TCr | |
+5.10% | 1.37TCr | |
+37.57% | 1.24TCr |
- Stock Market
- Equities
- VRNA Stock
- News Verona Pharma plc
- BTIG Boosts Price Target on Verona Pharma to $26 From $17, Reiterates Buy Rating